Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue 12, 2002, Pages 1291-1298

  Togawa, Jun Ichi ^a   Nagase, Hajime ^a   Tanaka, Katsuaki ^a   Inamori, Masahiko ^a   Nakajima, Atsushi ^a   Ueno, Norio ^a   Saito, Toshifumi ^a   Sekihara, Hisahiko ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Dextran sulfate sodium; Inflammatory bowel disease; Interleukin; Tumor necrosis factor

Indexed keywords

DEXTRAN SULFATE; DRINKING WATER; HEMOGLOBIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; LACTOFERRIN; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; DISEASE ACTIVITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; ENZYME ACTIVITY; HISTOPATHOLOGY; IMMUNOMODULATION; LEUKOCYTE COUNT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0036435816     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2002.02868.x     Document Type: Article

References (41)

1. Podolsky DK. Inflammatory bowel disease. N. Engl. J. Med. 1995;325: 928-35.
2. Elson CO, Sartor RB, Tennyson G, Riddel G. Experimental models of IBD. Gastroenterology 1995;109: 1344-50.
3. Matsuura T, West GA, Youngman KR, Klein JS, Flocchi C. Immune activation genes in inflammatory bowel disease. Gastroenterology 1993;104: 448-58.
4. Aggarwal BB, Puri RK. Human Cytokines: Their Role in Disease and Therapy. Boston: Blackwell, 1994; 1-120.
5. Andus T, Daig R, Lock G et al. Balance between pro- and anti-inflammatory cytokines in the colonic mucosa in inflammatory bowel disease (IBD). Gastroenterology 1995; 108: 770-8.
6. Niessner M, Volk BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin. Exp. Immunol. 1995;101: 428-35.
7. Gross V, Andus T, Caesar I, Roth M, Scholmerich J. Evidence for continuous stimulation of interleukin-6 production in Crohn's disease. Gastroenterology 1992;102: 514-19.
8. Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D. Role of interleukin-1 in inflammatory bowel disease-enhanced production during active disease. Gut 1990;31: 686-9.
9. Reinecker HC, Steffen M, Witthoeft T et al. Enhanced secretion of tumor necrosis factor-α, IL-6, and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin. Exp. Immunol. 1993;94: 174-81.
10. Lonnerdal B, Iyar S. Lactoferrin: molecular structure and biological function. Ann. Rev. Nutr. 1995;15: 93-110.
11. Crouch SP, Slater KJ, Fletcher J. Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood 1992;80: 235-40.
12. He J, Furmanski P. Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature 1995;373: 721-4.
13. Hutchens TW, Henry JF, Yip TT et al. Origin of intact lactoferrin and its DNA-binding fragments found in the urine of human milk-fed preterm infants. Evaluation by stable isotopic enrichment. Paediatr. Res. 1991;29: 243-50.
14. Mattsby-Baltzer I, Roseanu A, Motas C, Elverfors J, Engberg I, Hansen LA. Lactoferrin or a fragment thereof inhibits the endotoxin-induced IL-6 release response in human monocytic cells. Paediatr. Res. 1996;40: 257-62.
15. Te Velde AA, Huijbens RJ, Heije K, de Vries JE, Figdor CG. Interleukin-4 inhibits secretion of IL-1β, tumor necrosis factor α, and IL-6 by human monocytes. Blood 1990;76: 1392-7.
16. Togawa J, Nagase H, Tanaka K et al. Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. Am. J. Physiol. Gastrointest. Liver Physiol. 2002;283: G187-95.
17. Egger B, Bajaj-Elliot M, MacDonald TT, Inglin R, Eysselein VE, Buchler MW. Characterisation of acute murine dextran sulfate colitis: cytokine profile and dose dependency. Digestion 2000;62: 240-8.
18. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990;98: 694-702.
19. Yamauchi K, Toida T, Nishimura S. 13-week oral repeated administration toxicity study of bovine lactoferrin in rats. Food Chem. Toxicol. 2000;38: 503-12.
20. Cooper HS, Murphy SNS, Shah RS, Sedergran DJ. Clini-copathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 1993;69: 238-50.
21. Elson CO, Beagley KW, Sharmanov AT et al. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protections by tolerance. J. Immunol. 1996;157: 2174-85.
22. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989;96: 795-803.
23. Wallace JL, MacNaughton WK, Morris GP, Beck PL. Inhibition of leukotoriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology 1989;96: 29-36.
24. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 1982;78: 206-9.
25. Ameho CK, Adjei AA, Harrison EK et al. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumor necrosis factor α production in trinitrobenzen sulphonic acid induced colitis.Gut 1997;41: 487-93.
26. Hallahan DE, Mauceri HJ, Seung LP et al. Spatial and temporal control of gene therapy using ionizing radiation. Nature Med. 1995;1: 786-91.
27. Lopez-Talavera JC, Levitzki A, Martinez M, Gazit A, Esteban R, Guardia J. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxidase production in cirrhotic rats with portal hypertension and ascites. J. Clin. Invest. 1997;100: 664-70.
28. Hentges DJ, Marsh WW, Petschow BW, Thal WR, Carter MK. Influence of infant diets on the ecology of the intestinal tract of human flora-associated mice. J. Pediatr. Gastr. Nutr. 1992;14: 146-52.
29. Axelssoon LG, Landstom E, Bylund-Fellenius AC. Experimental colitis induced by dextran sulphate sodium in mice: benefical effects of sulphasalazine and olsalazine. Aliment. Pharmacol. Ther. 1998;12: 925-34.
30. Meeteren ME, Meijssen MAC, Zijistra FJ. The effect of dexamethasone treatment on murine colitis. Scand. J. Gastroenterol. 2000;35: 517-21.
31. Murphy SNS, Cooper HS, Shim H, Shah RS, Ibrahim SA, Sedergran DJ. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporine. Dig. Dis. Sci. 1993;38: 1722-34.
32. Olson ADI, Buino EA, Bitar KN, Remick DG. Antiserum to tumor necrosis factor and failure to prevent murine colitis. J. Pediatr. Gastr. Nutr. 1995;21: 410-18.
33. Duchmann R, Schmitt E, Knolle P, Meyer-zum-Buschenfelde KH, Neurath M. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur. J. Immunol. 1996;26: 934-8.
34. Ribbons KA, Thompson JH, Liu X, Pennline K, Clark DA, Miller MJS. Anti-inflammatory properties of interleukin-10 administration in hapten-induced colitis. Eur. J. Pharmacol. 1997;323: 245-54.
35. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis.Cell 1993;75: 263-74.
36. Schreiber S, Heinig T, Panzer U et al. Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease. Gastroenterology 1995; 108: 21-33.
37. Isaacs KL, Sartor RB, Haskill JS. Cytokine mRNA pro-files in inflammatory bowel disease mucosa detected by PCR amplification. Gastroenterology 1992;103: 1587-95.
38. Zimecki M, Miedzybrodzki R, Szymaniec S. Oral treatment of rats with bovine lactoferrin inhibits carrageenan-induced inflammation; correlation with decreased cytokine production. Arch. Immunol. Ther. Exp. 1998;46: 361-5.
39. Cumberbatch M, Dearman RJ, Uribe-Luna S. Regulation of epidermal Langerhans cell migration by lactoferrin. Immunology 2000;100: 21-8.
40. Harada E, Itoh Y, Sitizyo K, Takeuchi T, Araki Y, Kita-gawa H. Characteristic transport of lactoferrin from the intestinal lumen into the bile via the blood in piglets. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 1999;124: 321-7.
41. Vorland LH. Lactoferrin: A multifunctional glycoprotein. APMIS 1999;107: 971-81.